Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023

Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023

Objectives: We evaluated the vaccine effectiveness of monovalent XBB.1.5 vaccine against symptomatic COVID-19 infection, hospitalization, and the need for oxygen therapy in South Korea. Design: This study employed a test-negative case-control design. COVID-19 test results in symptomatic subjects fro...

Full description

Saved in:
Bibliographic Details
Main Authors: Jung Ah Lee, Heeseon Jang, Sang Min Ahn, Jae Eun Seong, Young Keun Kim, Yujin Sohn, Sook In Jung, Hye Won Jeong, Shin-Woo Kim, Jin-Soo Lee, Ji-Hyeon Baek, Se Ju Lee, Geun-Yong Kwon, Jeeyeon Shin, Hangjin Jeong, Changsoo Kim, Jun Yong Choi
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
Vaccine
Vaccine effectiveness
XBB.1.5
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971224003205
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S1201971224003205

Similar Items